Cargando…
Case Report: Early (68)Ga-PSMA-PET Metabolic Assessment and Response to Systemic Treatment for First-Line Metastatic Clear Cell Renal Cell Carcinoma; About Two Clinical Cases
Early evaluation of response to anticancer treatment in metastatic renal cell carcinoma (RCC) is challenging as responses are sometimes delayed, as mixed responses can occur, and as conventional imaging have some limitations. As PSMA has been previously identified in neovasculature of clear cell RCC...
Autores principales: | Seront, Emmanuel, Lhommel, Renaud, Tombal, Bertrand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689125/ https://www.ncbi.nlm.nih.gov/pubmed/34950588 http://dx.doi.org/10.3389/fonc.2021.782166 |
Ejemplares similares
-
Comparison of (68)Ga-Prostate Specific Membrane Antigen (PSMA) Positron Emission Tomography Computed Tomography (PET-CT) and Whole-Body Magnetic Resonance Imaging (WB-MRI) with Diffusion Sequences (DWI) in the Staging of Advanced Prostate Cancer
por: Van Damme, Julien, et al.
Publicado: (2021) -
(68)Ga-PSMA PET-CT Imaging of Metastatic Adenoid Cystic Carcinoma
por: de Keizer, Bart, et al.
Publicado: (2016) -
Pelvic salvage (SBRT) radiotherapy based on (68)Ga-PSMA PET/CT: About a case
por: Slaoui, A., et al.
Publicado: (2019) -
Musculoskeletal pitfalls in (68)Ga-PSMA
PET/CT
por: Pontes, Írline Cordeiro de Macedo, et al.
Publicado: (2023) -
Unexpected Metastatic Localizations of Prostate Cancer Determined by (68)Ga PSMA PET/CT: Series of Four Cases
por: Mütevelizade, Gözde, et al.
Publicado: (2022)